Menu

Intensity Therapeutics, Inc. (INTS) Q3 2026 Earnings Call Transcript
📰

Intensity Therapeutics, Inc. (INTS) Q3 2026 Earnings Call Transcript

All Articles on Seeking Alpha·12 days ago
#qNctAJtR
#seekingalpha#call#intensity#company#results
Reading 0:00
15s threshold

Intensity Therapeutics, Inc. ( INTS ) Q3 2026 Earnings Call November 5, 2026 8:00 AM EST

Company Participants

Lewis Bender - Founder, President, CEO & Chairman of the Board

Joseph Talamo - Chief Financial Officer

Conference Call Participants

Kumaraguru Raja - Brookline Capital Markets, LLC, Research Division

Charles Wallace - H.C. Wainwright & Co, LLC, Research Division

Ilya Zubkov - Freedom Broker, Research Division

James Molloy - Alliance Global Partners, Research Division

Conversation

Operator

Good morning, and welcome to the Intensity Therapeutics Third Quarter 2026 Financial Results Conference Call. Joining the call today is Lewis H. Bender, Intensity's President and CEO; and Joseph Talamo, Intensity's Chief Financial Officer.

Shortly before this call, Intensity issued a press release announcing its third quarter 2026 financial results, which is available under the News and Events section of the company website.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.